Morgan Stanley Reaffirms Their Sell Rating on Bristol Myers

Morgan Stanley analyst Terence Flynn maintained a Sell rating on Bristol Myers (BMY – Research Report) today and set a price target of $62...

Related Keywords

Terence Flynn , Bristol Myers , Morgan Stanley , Bristol Myers Squibb Co , Johnson , Eli Lilly Co , Research Report , Eli Lilly , Moderate Buy , New York Based Bristol Myers Squibb ,